Presenting Companies ⇽ BioSeed 2023, Monday 23 January, LONDON

This is a past event. Registration is closed. View other OBN events.

Ali Al-khattawi

CEO of MESOX

https://www.mesox.co.uk

Jenny Bailey

CEO of Ferryx

https://www.ferryx.com/

Dr Jenny Bailey is Co-founder of Ferryx Ltd and is responsible for developing and delivering the company strategy. She has a PhD in gastrointestinal immunology and 16 years’ research experience in gastrointestinal disease in humans and animals. Jenny has been responsible for the development of FX856 since its early stages and has led its commercialisation over the last two years.

Alex Batchelor

CEO of Pictura Bio (OX Dx)

https://www.oxdx.com

Pedro Correa de Sampaio

CEO of Neobe Therapeutics

https://www.neobetherapeutics.com/

Giles Dudley

CBO at Stimuliver

https://www.stimuliver.bio/

Erwan Eriau

President at Therafast Bio

Digvijay Gahtory

CEO of BIMINI Biotech

https://biminibiotech.nl/

John Gleeson

CEO of Tympulse Medical

https://www.rcsi.com/dublin/research-and-innovation/innovation/investors-and-entrepreneurs

Tristan Heintz

Scientific Director of Rejuveron Vascular Therapeutics

https://rejuveron.com/en/

Michael Hunt

CEO of NK:IO Ltd

https://nk-io.com/

Aditya Varna Iyer

Director of Allos AI

https://www.allos.ai/

Agnieszka Janeczek

CEO of Renovos Biologics Limited

https://www.renovos.co.uk/

Zahra Jawad

CEO Founder of Creasallis

https://www.creasallis.com/

Andreas Jensen

CEO of Tetrakit

https://tetrakit.com/

Niels Jerichau Clausen

CEO of HHC Medical

https://hhc-medical.com/

Endre Kiss-Toth

CEO, Founder of Stem CellX Limited

https://stemcellx.com/

Anders Klein

CSO & Co-Founder of Ousia Pharma

https://ousiapharma.com/

Paul Ko Ferrigno

CEO of éclateral Ltd

https://www.eclateral.com/

Kaido Kurrikoff

CEO of Vectiopep

https://www.linkedin.com/company/vectiopep/

Tiina Kähkönen

OncoBone Ventures Limited

https://www.oncoboneventures.com/

Nuno Madeira do O

CEO of Reflection Therapeutics

https://www.reflectiontherapeutics.com

Abigail Martin

CEO of ImmuOne

https://immuone.com/

Ajay Mistry

CEO/Founder of Oppilotech

https://oppilotech.com/

Jeffrey Moore

Founder & CEO of Curileum Discovery

https://www.curileum.com/

Lasse Nørregaard

CBO at PrOBMet

https://probmet.com/

Marie O'Brien

Dr/Co-founder and Chief Scientific Officer of ReNewVax Ltd

https://www.renewvax.com/

Ryan Pink

CEO of MetaGuideX Ltd

https://metaguidex.com/

Jon Preece

CEO of ChromaTwist

https://chromatwist.com/

Jon Rees

Chief Executive Officer & Co-Founder of MitoRx Therapeutics

https://www.mitorxtherapeutics.com/

Pierre Rocheteau

CEO of Olgram

https://www.olgram.com/en

Bart Roman

Dr. / Amalus Program Manager at Amalus Therapeutics

Katrin Rupalla

CEO of Ymmunobio AG

https://www.ymmunobio.com/

Jeremy Salt

CEO of TVG

https://thevaccinegroup.com/

David Sarphie

CEO of Seroxo Ltd

https://seroxo.com/index.html

Arne Scheu

CEO of LiliumX

https://www.liliumx.com

Arne is Co-Founder and CEO of LiliumX. He completed his DPhil at the University of Oxford as a Rhodes Scholar, his prior research was on the development of a novel technology for stable modification of endogenous proteins. He has continuously sought to apply his research, and LiliumX combines his passion for protein engineering with his eagerness to deliver novel therapeutics.

Kirsty Semple

CEO of SENISCA Ltd

https://www.senisca.com/

Kirsty is co-founder, and the commercial, finance and investment lead at SENISCA. She is an accomplished Chief Executive Office, with over 20 years of experience at Group Board level maximising profitability and performance at high growth companies across Europe, Asia and North America. Kirsty trained as a Management Consultant with KPMG London and is a prize-winning Cell Physiology graduate from Edinburgh University.